WellMedr lands at #58 on our women's ranking with a Luna Fit Score of 67/100 — what we found reviewing WellMedr goes through the six factors behind that number. If it isn't the right fit, here are the strongest alternatives for women's GLP-1 care — scored on the same women's-health rubric of PCOS suitability, clinical oversight, price, access, support and fair cancellation.
Our #1 pick for women
Luna Fit
93/100
Ranked #1 · Grade A
CoreAge Rx
The most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
That is 26 points above WellMedr on the Luna Fit Score (93 to 67). Price, coverage and every factor are set out side by side in the WellMedr–CoreAge Rx head-to-head.
Everything below is scored on the same six women's-health factors as WellMedr, in our overall ranking order — our complete review index has the rest of the ranking.
Enhance MD
Ranked #2 · Grade A−
Luna Fit
92/100
A tiered compounded program that lays every price on the table — semaglutide, tirzepatide, a microdose lane, and a combo option — with six-month metabolic lab testing and an NAD+ adjacency that speaks to women thinking about metabolism as a whole system.
Both molecules at prices you can see up front, wrapped in a wider menu — NAD+, microdosing, and an optional coaching-and-labs bundle — for a woman who wants weight care and energy alongside it.
An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.
A LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injections — both molecules, transparent no-insurance pricing, and an accreditation signal that reassures when hormones are in play.
Among the lowest verified prices we log — compounded semaglutide and tirzepatide on a single membership, shipped nationwide. A budget-first on-ramp for women who want tirzepatide access without paying a premium.
An insurance-first GLP-1 marketplace that shops a reader's coverage for her — down to $99/mo with qualifying insurance, or $50/mo for eligible Medicare Part D members through its CMS Bridge program — with one of the widest medication menus in this ranking, including an oral pill option.
One of the few programs with a women's weight-loss line of its own, and the widest set of routes we track — injectable or sublingual, semaglutide or tirzepatide, each with its price on the page.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Scores are our editorial judgment per the methodology. Not medical advice; see our disclosure.